Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Benjamin Palleiko

Benjamin Palleiko

Chief Executive Officer, KalVista Pharmaceuticals

Appears in 1 story

Notable Quotes

This combination ensures EKTERLY reaches patients globally far faster than we could alone, Palleiko said in the joint statement.

Stories

Chiesi acquires KalVista as pharma deepens rare disease push

Money Moves

Selling company after one year of commercial sales

For decades, people with hereditary angioedema had one option when an attack hit: inject themselves, often in a panic. In this genetic condition, the immune system misfires and swells tissues shut—sometimes fatally, closing the airway. In July 2025, a pill changed that.

Updated May 31